MONTCLAIR, New Jersey (June 15, 2026) – Hackensack Meridian Mountainside Medical Center is proud to announce that it has successfully performed its first Aquablation therapy case using the new HYDROS™ Robotic System, an advanced AI-powered technology designed to treat benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.
BPH is a common condition associated with aging that affects millions of men and can significantly impact urinary function. Symptoms often include difficulty urinating, an inability to fully empty the bladder, frequent urination—especially at night—and a sudden or urgent need to urinate. Without timely treatment, BPH may lead to serious complications such as bladder or kidney damage, bladder stones, and incontinence. Approximately one in two men ages 51–60 experience BPH, and many report a reduced quality of life as a result. While surgery is the standard treatment option, it has been associated with potential side effects, including impacts on sexual function and continence.
The HYDROS™ Robotic System is the next step forward in Aquablation therapy. Built on experience from more than 50,000 procedures, it uses AI planning, advanced imaging, and robotic technology to help doctors work more efficiently and deliver consistent results.
The system gives the surgeon a detailed, full view of the prostate using ultrasound and a small camera. This allows them to create a treatment plan tailored to each patient. It then uses a precise, heat-free waterjet to remove blocked tissue while protecting important areas, helping reduce side effects.
Aquablation therapy has been shown in five-year studies to provide lasting symptom relief while preserving sexual function and bladder control.
“For many men over age 50, symptoms related to an enlarged prostate can interfere with comfort, sleep, and everyday activities,” said Dr. Michael Benson, Urologist at Mountainside Medical Center. “Aquablation therapy offers a minimally invasive, advanced treatment option that can provide lasting symptom relief while helping preserve the quality-of-life outcomes that matter most to patients.”
For more information about Aquablation therapy at Mountainside Medical Center at www.mountainsidemedicalcenter.com.
About Mountainside Medical Center
Mountainside Medical Center has been a trusted provider of healthcare in Montclair and surrounding New Jersey communities since 1891. The hospital is home to specialized centers for imaging, women’s health, cancer care, cardiac care, surgery, weight management, stroke, and chronic kidney disease. Designated as a Primary Stroke Center by the NJ State Department of Health and Senior Services, Mountainside is one of the few community hospitals in the state licensed to perform emergency cardiac angioplasty, offering advanced, life-saving care close to home.
The hospital also features Mountainside Medical Group with expert physicians across primary care and various specialties, ensuring seamless and coordinated care for patients. With conveniently located offices in Montclair, Glen Ridge, Clifton and nearby towns, Mountainside Medical Center makes accessing quality healthcare simple and accessible. To learn more, visit www.mountainsidemedicalcenter.com.
###